drugset / Trial / NCT02342470

Efficacy and Safety of PMK-S005 in the Prevention of Recurrent Peptic Ulcer in Low-dose Aspirin Users

NCT02342470 ↗

Phase 2 Completed 88 enrolled PharmaKing
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The purpose of this study is to evaluate the efficacy and safety by comparing prevention of recurrent peptic ulcer in low-dose aspirin users between PMK-S005 and Placebo.

Timeline

Start
2014-11-24
Primary completion
2017-12-08
Completion
2017-12-08

Drugs

EvaluationDrugModalityDoseRoute
Subject PMK-S005 Unknown 50 mg Oral
Subject PMK-S005 Unknown 100 mg Oral
Subject PMK-S005 Unknown 150 mg Oral

Indications